Simplex Trading
FHTX icon

Simplex Trading’s Foghorn Therapeutics FHTX Stock Holding History

Simplex Trading’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478 Hold
100
– – ﹤0.01% 8740
2025
Q4 		$540 Sell
100
-300
-75% -$1.36K ﹤0.01% 8147
2025
Q3 		$1K Buy
+400
New +$2.12K ﹤0.01% 8803
2025
Q1 		– Sell
-1,000
Closed -$4K – 8826
2024
Q4 		$4K Sell
1,000
-300
-23% -$2.19K ﹤0.01% 7725
2024
Q3 		$12K Buy
+1,300
New +$9.41K ﹤0.01% 7059
2023
Q4 		– Sell
-500
Closed -$2K – 9096
2023
Q3 		$2K Sell
500
-10,600
-95% -$81.7K ﹤0.01% 8085
2023
Q2 		$78K Buy
+11,100
New +$77.6K ﹤0.01% 5357
2023
Q1 		– Sell
-800
Closed -$5K – 9333
2022
Q4 		$5K Hold
800
– – ﹤0.01% 8047
2022
Q3 		$6K Buy
800
+600
+300% +$7.72K ﹤0.01% 8636
2022
Q2 		$2K Hold
200
– – ﹤0.01% 9334
2022
Q1 		$3K Buy
200
+100
+100% +$1.37K ﹤0.01% 9687
2021
Q4 		$2K Buy
+100
New +$1.44K ﹤0.01% 9982

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's FHTX Position: Q1 2026 in Review

Simplex Trading opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 66 shares worth $315. The stake represents ﹤0.01% of the portfolio and ranks #8791 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FHTX as recently as Q2 2025.

Simplex Trading first reported a position in FHTX in Q4 2021 and has held it in 8 quarters since. The position peaked at $126K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Simplex Trading held 66 shares of Foghorn Therapeutics worth $315 as of Q1 2026.
  • Foghorn Therapeutics was a new Simplex Trading position in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8791 holding.
  • Simplex Trading first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • Simplex Trading's Foghorn Therapeutics position peaked at $126K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.